« Previous
Next »
Journal of Hepatology
Volume 56, Issue 5
, Pages 1129-1135
, May 2012
Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma
To access this article, please choose from the options below
PII: S0168-8278(12)00055-4
doi: 10.1016/j.jhep.2011.12.016
© 2012 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 56, Issue 5
, Pages 1129-1135
, May 2012
